These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24901647)
41. [Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice]. Liu L; Chen BA; Qin SK Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):67-72. PubMed ID: 21434348 [TBL] [Abstract][Full Text] [Related]
42. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. Yang MH; Zang YS; Huang H; Chen K; Li B; Sun GY; Zhao XW Curr Cancer Drug Targets; 2014; 14(6):557-66. PubMed ID: 25088040 [TBL] [Abstract][Full Text] [Related]
43. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro. Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226 [TBL] [Abstract][Full Text] [Related]
44. Resveratrol ameliorates the oxidative damage induced by arsenic trioxide in the feline lung. Cheng Y; Xue J; Yao C; Gao L; Ma D; Liu Y; Zhang Z J Vet Med Sci; 2013; 75(9):1139-46. PubMed ID: 23595121 [TBL] [Abstract][Full Text] [Related]
45. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice. Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138 [TBL] [Abstract][Full Text] [Related]
46. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors. Wu EJ; Goussetis DJ; Beauchamp E; Kosciuczuk EM; Altman JK; Eklund EA; Platanias LC Cancer Biol Ther; 2014 Apr; 15(4):473-8. PubMed ID: 24496081 [TBL] [Abstract][Full Text] [Related]
47. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107 [TBL] [Abstract][Full Text] [Related]
48. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). Michel L; Dupuy A; Jean-Louis F; Sors A; Poupon J; Viguier M; Musette P; Dubertret L; Degos L; Dombret H; Bachelez H J Invest Dermatol; 2003 Oct; 121(4):881-93. PubMed ID: 14632209 [TBL] [Abstract][Full Text] [Related]
49. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. Baumgartner M; Sturlan S; Roth E; Wessner B; Bachleitner-Hofmann T Int J Cancer; 2004 Nov; 112(4):707-12. PubMed ID: 15382055 [TBL] [Abstract][Full Text] [Related]
50. A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer. Ahn RW; Chen F; Chen H; Stern ST; Clogston JD; Patri AK; Raja MR; Swindell EP; Parimi V; Cryns VL; O'Halloran TV Clin Cancer Res; 2010 Jul; 16(14):3607-17. PubMed ID: 20519360 [TBL] [Abstract][Full Text] [Related]
51. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide. Shao QS; Ye ZY; Ling ZQ; Ke JJ World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253 [TBL] [Abstract][Full Text] [Related]
52. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia. La Rosée P; Johnson K; O'Dwyer ME; Druker BJ Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670 [TBL] [Abstract][Full Text] [Related]
53. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686 [TBL] [Abstract][Full Text] [Related]
54. Involvement of Mitochondrial Damage and Oxidative Stress in Apoptosis Induced by Betulin Plus Arsenic Trioxide in Neuroblastoma Cells. Chen KY; Hsu WL; Hsu SW; Chen CH; Hong KT; Tsai CW; Chang WS; Chen CC; Pei JS; Lee HT; Bau DT Anticancer Res; 2023 Jun; 43(6):2467-2476. PubMed ID: 37247918 [TBL] [Abstract][Full Text] [Related]
56. [Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model]. Du CW; Li DR; Lin YC; Wu MY Ai Zheng; 2003 Jan; 22(1):21-5. PubMed ID: 12561430 [TBL] [Abstract][Full Text] [Related]
57. Resveratrol, a natural antioxidant, has a protective effect on liver injury induced by inorganic arsenic exposure. Zhang Z; Gao L; Cheng Y; Jiang J; Chen Y; Jiang H; Yu H; Shan A; Cheng B Biomed Res Int; 2014; 2014():617202. PubMed ID: 25147808 [TBL] [Abstract][Full Text] [Related]
58. The effects of ultrasound and arsenic trioxide on neurogliocytoma cells and secondary activation of macrophages. Xu Y; Zhang Y; Liu X; Wang Z; Ma J; Wang J; Yue W Tumori; 2009; 95(6):780-8. PubMed ID: 20210244 [TBL] [Abstract][Full Text] [Related]
59. Cathepsin L silencing increases As Primon M; Huszthy PC; Motaln H; Talasila KM; Miletic H; Atai NA; Bjerkvig R; Lah Turnšek T Exp Cell Res; 2017 Jul; 356(1):64-73. PubMed ID: 28412241 [TBL] [Abstract][Full Text] [Related]
60. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells. Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]